Clinical Trial Analysis
Clinical Trial Analysis are critical in conducting medical research. These are designed to map and test new treatments such as new approaches, new drugs, new vaccines for disease prevention and diagnosis. The choice of the trial process is crucial as it determines inferences that may be drawn from such a trial. They closely consider the ethical acceptability, the extent to which bias in conducting and examining the study can be minimized, the kind of subjects that can be engaged, the acceptability of the results by the regulatory authorities along with other aspects of the study.
Molecular Connections’ Clinical Trial Analysis team assists pharmaceutical and biotech companies in executing systemic evaluation of clinical trial data and helps with meta-analysis to determine and extract important drug characteristics, such as safety and efficacy of drugs, among other details, in comparison to their competitors’ drugs.
Select Case Studies
Mining clinical trials by combining automated and manual curation
This case study outlines two independent investigations using the clinical trial data to provide information for the clinical trial decision makers – the first identifies all the late stage combinatorial therapies within the therapeutic space of NSCLC and the second identifies the comparator drugs in the late stage trials.
Follow Us on
Our Product Line
Request additional information on Clinical Trial Analysis
Got questions? Need more info? Fill out the form and our team will get back to you soon.